Contact number
+1 202 857 6000Chambers Review
Strong team noted for its handling of wide-ranging matters, including regulatory compliance, external investigations and litigation. Particularly adept at fraud and abuse matters, with significant expertise in high-stakes False Claims Act matters. Also offers experience in drug pricing and FDA regulatory issues for pharmaceutical and medical device companies.
Work Highlights
- ArentFox provided counsel to Apotex Corporation on government price reporting, among other issues.
Strengths
Provided by Chambers
"The ArentFox team are great to work with and true experts in their respective fields."
"ArentFox Schiff has a very strong team with a deep bench. The team has members with a variety of perspectives and is able to view a topic from all angles and figure out the best approach."
"The advice the team provides is clear and concise."
"The ArentFox team are great to work with and true experts in their respective fields."
"ArentFox Schiff has a very strong team with a deep bench. The team has members with a variety of perspectives and is able to view a topic from all angles and figure out the best approach."
"The advice the team provides is clear and concise."
Notable Practitioners
Brian Waldman counsels on a wide range of issues including FDA compliance, licensing and pricing matters. He also has experience of fraud and abuse counseling.
"He is very client-focused and gives very good advice."
"Brian provides excellent, commercially minded advice."
Stephanie Trunk comes recommended for her pharmaceutical pricing practice. She also offers a broad range of experience in healthcare regulatory issues such as fraud and abuse matters.
"Stephanie is efficient, thoughtful and responsive."
"She is extremely knowledgeable."
Jacques Smith has impressive litigation experience and is frequently sought after in FCA, drug pricing and anti-kickback disputes.
"Jacques is very responsive, thoughtful, gives great advice and is a strategic thinker."
"His biggest strength is his depth of experience."